These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27926519)

  • 21. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
    Yan SR; Liu ZJ; Yu S; Bao YX
    Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
    Liu T; Yin L; Yan G; Li C; Wang L
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-200 as potential diagnostic markers for colorectal cancer: meta-analysis and experimental validation.
    Peng Z; Zhu W; Dai J; Ju F
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):77-85. PubMed ID: 29808805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis.
    Sun C; Zhu J; Wu B; Chen J; Zhu Z; Cai P; Guo W; Gu Z; Wang J; Huang S
    Cancer Manag Res; 2018; 10():2125-2139. PubMed ID: 30050323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
    Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNAs as Diagnostic and Prognostic Indicators of Colorectal Cancer: A Pooled Analysis of Individual Studies.
    Long C; Xu QB; Ding L; Huang LJ; Ji Y
    Pathol Oncol Res; 2022; 28():1610037. PubMed ID: 35369570
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
    Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
    J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.
    Bullock MD; Pickard K; Mitter R; Sayan AE; Primrose JN; Ivan C; Calin GA; Thomas GJ; Packham GK; Mirnezami AH
    Oncotarget; 2015 Mar; 6(9):7262-79. PubMed ID: 25788261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
    Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.
    Nagano Y; Toiyama Y; Okugawa Y; Imaoka H; Fujikawa H; Yasuda H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2016 Dec; 36(12):6521-6526. PubMed ID: 27919977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis.
    Wei HT; Guo EN; Dong BG; Chen LS
    BMC Gastroenterol; 2015 Oct; 15():152. PubMed ID: 26518017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis.
    Xia W; Chen W; Zhang Z; Wu D; Wu P; Chen Z; Li C; Huang J
    PLoS One; 2015; 10(4):e0123484. PubMed ID: 25856316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis.
    Zhou XJ; Dong ZG; Yang YM; Du LT; Zhang X; Wang CX
    Asian Pac J Cancer Prev; 2013; 14(8):4699-704. PubMed ID: 24083729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic value of DNA hypermethylation in stool for colorectal cancer: a meta-analysis.
    Qian LY; Zhang W
    J Cancer Res Ther; 2014 Dec; 10 Suppl():287-91. PubMed ID: 25693937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.